- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07263243
Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women
December 5, 2025 updated by: Rokaia Ali Zainelabedeen Mohamed Toson, Cairo University
Obesity has become a major global public health issue, defined by an excessive accumulation of body fat that presents substantial health risks.
Over 650 million adults worldwide suffer from obesity, which is defined as having a Body Mass Index (BMI) of 30 or higher.
Obesity is becoming more common in both developed and developing countries.
Sedentary lifestyles, unhealthy eating habits that include processed foods and sugars, and genetic factors are the main causes of the rising prevalence of obesity.
Obesity is a multifactorial condition that affects physical appearance and self-esteem, while also having significant implications for long-term health, leading to decreased life expectancy and lower quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nesma Morgan Allam, Assistant Professor
- Phone Number: +2 1281968332
Study Contact Backup
- Name: Rokaia Ali Toson Assistant Professor of Physical Therapy, Assistant Professor
- Phone Number: +2/01061259678
- Email: Rokaiazain@yahoo.com
Study Locations
-
-
-
Jouf, Saudi Arabia
- Recruiting
- Jouf University
-
Contact:
- Rokaia Ali Toson, phD
- Phone Number: +201061259678
- Email: rokaiazain@yahoo.com
-
Contact:
- Nesma Morgan Allam, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Females aged 18 to 25.
- normotensive (<140/90 mmHg).
- Their BMI was from 25 to 40 kg/m2.
- Sedentary (≤ 90min of regular exercise per week).
Exclusion Criteria:
- Having previously diagnosed with any chronic disease.
- Cardiorespiratory or neuromuscular conditions.
- Participating in any exercise program.
- Patients with a pacemaker.
- Pregnancy.
- Smoking.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study Group (Whole body vibration group)
The study group (no = 13) underwent single session of whole-body vibration (WBV) of using the PowerPlate device.
|
Whole-body vibration (WBV) training using the Power Plate Pro 7HC (Northbrook, USA).
The vibration frequency was set at 30 Hz, with an amplitude of 2 mm.
|
|
Experimental: Control group (Sham whole body vibration group)
The sham WBV group (no=13) will stand on the same device with the vibtation shut off for single session.
|
A sham Whole body vibration will be used .
participants will stand on the device without actual vibrations.This control condition will be used to isolate the effects of WBV from other potential influences such as standing posture and time spent on the the platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brachial blood pressure
Time Frame: 1 day
|
Systolic brachial blood pressure and diastolic brachial blood pressure will be measured using a blood pressure (BP) monitoring device after 15 minutes rest.
|
1 day
|
|
Heart rate
Time Frame: 1 day
|
Heart rate will be measured using a pulse oximeter after 15 minutes rest.
|
1 day
|
|
Arterial O2 saturation
Time Frame: 1 day
|
Arterial oxygen saturation of pulse oximetry (SpO2) were measured using a pulse oximeter.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Minute walk test
Time Frame: 1 day
|
The 6-Minute Walk Test (6MWT) is a simple, practical assessment used to measure functional exercise capacity.
It evaluates how far a person can walk on a flat, hard surface (usually 30 meters) in six minutes.
It is widely used in cardiology, pulmonology, and rehabilitation.
|
1 day
|
|
The Borg scale
Time Frame: 1 day
|
The Borg Scale is a tool used to measure a person's perceived exertion and how hard they feel they are working during physical activity.
It is commonly used during cardiac rehab, pulmonary rehab, exercise training, and clinical assessments.
the scale ranges from 6 represents no exertion at all and to 20 represents maximal exertion.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 24, 2026
Primary Completion (Estimated)
February 24, 2026
Study Completion (Estimated)
February 24, 2026
Study Registration Dates
First Submitted
November 23, 2025
First Submitted That Met QC Criteria
November 23, 2025
First Posted (Estimated)
December 4, 2025
Study Record Updates
Last Update Posted (Actual)
December 12, 2025
Last Update Submitted That Met QC Criteria
December 5, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7699
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight , Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
Clinical Trials on Whole-body vibration device
-
Cairo UniversityCompletedObesity | OverweightSaudi Arabia
-
Koç UniversityCompletedPostpolio SyndromeTurkey
-
University of LiegeCompleted
-
University of Erlangen-Nürnberg Medical SchoolElsbeth-Bonhoff-Stiftung, BerlinTerminatedPostmenopausalGermany
-
Çağtay MadenCompletedWhole Body VibrationTurkey
-
The Hong Kong Polytechnic UniversityCompleted
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Gazi UniversityGulhane Training and Research HospitalCompletedArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
The Hong Kong Polytechnic UniversityUnknown